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 Glaucoma, the second leading cause of blindness world-
wide, represents a group of disorders with varied clinical symp-
toms [1]. The underlying molecular mechanism is still un-
known although 7 chromosomal loci (GLC1A to GLC1G) have
been mapped for primary open angle glaucoma (POAG) and
3 (GLC3A to GLC3C) for primary congenital glaucoma (PCG),
of which only GLC1A (Myocilin), GLC1E (Optineurin) and
GLC3A (CYP1B1) have been characterized [1-3]. The myocilin
gene (MYOC) exhibits a wide spectrum of mutations and ac-
counts for 2-5% cases of POAG [1]. Some pathogenic muta-
tions (e.g., Gln368Stop) are widely prevalent while others are
recurrent (Gly252Arg, Gly367Arg, and Pro370Leu) in vary-
ing frequencies in different populations [1-3]. The limited stud-
ies done on Indian POAG patients suggest that the Gln48His
mutation in MYOC recurs in different ethnic groups but is re-
stricted to the people of Indian origin according to the pub-
lished literature [4,5]. In this context, we attempted to investi-
gate the prevalence of the myocilin mutation (Gln48His)
among Indian glaucoma patients comprising of POAG and
PCG cases.
METHODS
 The study protocols adhered to the tenets of the Declaration
of Helsinki and were approved by the Institutional Review
Board. Two hundred cases each of POAG and PCG were re-
cruited from the southern (37.5%), eastern (35.5%), western
(13.5%), and northern (23.5%) parts of India.
Cases were enrolled as POAG on the basis of an elevated
intraocular pressure of >21 mm Hg and/or glaucomatous disc
changes in the presence of typical field defects, along with an
open angle on gonioscopy and no other secondary causes.
Cases of ocular hypertension were excluded from this category.
On the other hand, PCG cases were included on the basis of
an increased corneal diameter (>12.0 mm) along with raised
intraocular pressure (>21 mmHg) and/or presence of Haab’s
striae, or optic disc changes (where examination was possible).
The ages of onset ranged from 0-1 years and symptoms of
epiphora, photophobia, and rupture in the Descemet’s mem-
brane were the corroborating factors. Three hundred ethni-
cally matched normal individuals without any signs or symp-
toms of glaucoma and other systemic diseases served as con-
trols. Their visual acuity ranged from 20/20 to 20/40 and IOP
was <21 mm Hg. Clinical examination on stereo biomicros-
copy did not reveal any changes in the optic disc suggestive
of glaucoma.
Collection of blood samples and genomic DNA prepara-
tion, polymerase chain reaction (PCR), and the Gln48His
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mutation screening by digesting the PCR amplicons with AccI
restriction enzyme were done as described earlier [4]. The loss
of the AccI site suggested presence of the mutation (c.144G>T)
which was confirmed by direct sequencing. The patients con-
taining the mutant MYOC allele was screened for the CYP1B1
mutation by direct sequencing as described earlier [6].
RESULTS & DISCUSSION
 Among 200 POAG cases we identified 4 individuals carrying
the MYOC Gln48His mutation (Table 1), including 3 mutants
reported earlier [4]. One of the patients was also heterozy-
gous for a CYP1B1 mutation (c.1656C>T; Pro437Leu) sug-
gesting a digenic inheritance, as shown in a JOAG family [2],
which could not be investigated further because one of the
proband’s parents and his siblings were deceased. In addition,
other studies from India have reported two other POAG cases
harboring the same mutation [5]. These observations clearly
establish that Gln48His is a common mutation among Indian
patients which, however, has not yet been reported from any
other population.
 We also screened 200 PCG cases for the MYOC Gln48His
mutation and identified 5 cases harboring the mutant allele
(Table 1), which also included one homozygote (Table 2).
Among Indian PCG cases about 40% are CYP1B1 mutants
[6]. Interestingly, 4 of the 5 PCG cases harboring MYOC mu-
tation lacked any CYP1B1 defect. The presence of Gln48His
in the homozygous state in one PCG case devoid of any
CYP1B1 mutation, and absence of the Gln48His mutation in
300 ethnically matched normal controls strongly argue for the
role of the mutant MYOC protein causing PCG. However, no
study has yet described the functional mechanism for the in-
volvement of MYOC in PCG; although an earlier study showed
that heterozygous MYOC and CYP1B1 mutations cause JOAG
through a digenic mechanism. It was also hypothesized that
CYP1B1 may be a modifier of MYOC expression and these
two genes might act through a common biochemical pathway
[2]. It is worthwhile to mention here that there are examples
of single gene defects (e.g., RDS/peripherin) manifesting clini-
cally distinguishable eye diseases [7].
The PCG proband homozygous for the MYOC mutation
(Gln48His) was born out of a consanguineous marriage, as
evident by homozygous genotypes of markers in the patient
(data not shown). However, we did not have the opportunity
to investigate the segregation of the MYOC mutant alleles in
this family because the parents and siblings were deceased.
Clinically this patient had a relatively severe phenotype (Cor-
neal diameter 14 mm, total cupping, and an IOP of 74 and 50
mm Hg in the right and left eyes, respectively) compared to
other PCG patients with the heterozygous MYOC mutation
[8]. The outcome in terms of vision and IOP control (on treat-
ment) was also poor. Interestingly, it has been shown in a large
French-Canadian family that homozygotes for a MYOC mis-
sense mutation (Lys423Glu) are asymptomatic while heterozy-
gotes are affected with POAG suggesting a dominant nega-
tive effect in single dosage of the defective MYOC rather than
haploinsufficiency in this family [9]. Thus our observation in
homozygous MYOC mutant (Gln48His) is remarkably differ-
ent, which suggests that accumulation of much larger dataset
and functional studies might shed more light to decipher the
biology of pathogenesis of glaucoma.
It is possible that for the other 3 PCG cases lacking the
CYP1B1 mutation, some other yet unidentified locus together
with the MYOC Gln48His mutation might be involved in the
causation of the disease. In one PCG patient having one mu-
tant allele each for CYP1B1 (c.1449G>A; Arg368His) and
MYOC (c.144G>T; Gln48His), the disease might be caused
by digenic inheritance, as proposed for JOAG [2]. The father
and the mother of this patient were heterozygous for the mu-
tant MYOC and CYP1B1 alleles, respectively, and did not
manifest any glaucomatous symptoms [8]. Although it has been
hypothesized that CYP1B1 could be a modifier of MYOC ex-
pression and that these two genes might act through a com-
mon biochemical pathway [2], there are no functional evi-
dences so far to support this point. The genotypes of all nine
patients with Gln48His mutation are described in Table 2.
Although we cannot ascribe causality of all glaucoma phe-
notypes to the Gln48His mutation alone, it is likely to be a
potential risk factor towards disease predisposition. Hence we
recommend the screening for this MYOC mutation in all glau-
coma patients of Indian origin. The study presented here sug-
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TABLE 1. DISTRIBUTION OF MYOCILIN MUTATION GLN48HIS AMONG
THE INDIAN GLAUCOMA PATIENTS
                          Number of
             Number of    Gln48His
Phenotype   individuals   mutations
---------   -----------   ---------
 POAG           200       4 (2.0%)
 PCG            200       5 (2.5%)
 Normal         300       0
In addition to the data presented below, Sripriya et al. [5] reported a
Gln48His mutation in two Indian POAG patients out of 100 screened
for defects in MYOC.
TABLE 2. GENOTYPE AND PHENOTYPE OF GLAUCOMA PATIENTS WITH
THE MYOC GLN48HIS MUTATION
                                         Genotypes
                       Age at    -------------------------
Patient               symptom      MYOC          CYP1B1
Number    Phenotype    onset      (c.144)    (c.1449/c.1656)
-------   ---------   --------   ---------   ---------------
1           POAG      37 years   (G,’T’)      (G,G)/(C,’T’)
2           JOAG         -       (G,’T’)      (G,G)/(C,C)
3           POAG         -       (G,’T’)      (G,G)/(C,C)
4           JOAG         -       (G,’T’)      (G,G)/(C,C)
5           PCG       at birth   (‘T’,’T’)    (G,G)/(C,C)
6           PCG       at birth   (G,’T’)      (G,G)/(C,C)
7           PCG       at birth   (G,’T’)      (G,G)/(C,C)
8           PCG       4 months   (G,’T’)      (G,G)/(C,C)
9           PCG       at birth   (G,’T’)      (G,’A’)/(C,C)
Among all the nine patients harboring the myocilin (NM_000261)
mutation, two were also heterozygous for CYP1B1 (NM_000104)
mutations. Three of the POAG patients (patient 2, 3, and 4) have
been described before [4]. The mutant alleles are enclosed by apos-
trophes. MYOC mutation: c.144G>T, Gln48His; and CYP1B1 muta-
tions: c.1449G>A, Arg368His and c.1656C>T; Pro437Leu.
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gests that the MYOC mutation could be associated to different
subtypes of glaucoma that need to be further investigated to
better appreciate the role of MYOC in glaucoma pathogen-
esis.
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